In the News

Liquid Biopsy Platform Demonstrates High Diagnostic Capabilities In Early Stages of Nasopharyngeal Carcinoma

May 31, 2019Onco’Zine

Commercial-stage medical technology company Laboratory for Advanced Medicine (LAM) announced positive results from a new study that evaluated DNA methylation-based marker panel for early diagnosis of nasopharyngeal carcinoma (NPC).

Read More

LAM Aims to Apply Methylation Cancer Testing to Blood

April 29, 2019

One of the potential flaws of liquid biopsy tests that rely on the detection of tumour DNA in a patient’s blood is that the tumour has to grow to a sufficient size to shed appreciable quantities of genetic material, making detection at an early, relatively treatable stage of disease that much harder. Laboratory for Advanced Medicine, or LAM, reckons it has found a better way. Its IvyGene tests work by detecting methylation levels of DNA, a gene expression marker that correlates with cancer...

Read More

Blood Test for Early Stage Cancer Diagnosis: Interview with Dr. Van Etten, CMO of Laboratory for Advanced Medicine

March 14, 2019

The Laboratory for Advanced Medicine (LAM), a biotechnology company headquartered in the US, offers non-invasive, early stage cancer detection tests that will use the IvyGene Platform. These IvyGene tests are based on detecting genomic DNA shed by cancer cells into the blood stream. By assessing cell-free DNA found in blood samples, the company can measure the extent to which methyl groups are present in DNA at certain locations in order to detect the presence of...

Read More

Laboratory for Advanced Medicine Plans More Cancer Tests, More Hires

January 24, 2019

Laboratory for Advanced Medicine (LAM) says its plans for this year include developing and commercializing more of its early cancer detection tests, expanding its portfolio beyond the four for which it has achieved validation, as well as growing its commercial staff and moving into its new headquarters.

Read More

Blood test offers early detection for cancer patients

October 28, 2018

A new blood test could help detect cancer as early as stage one, and one Long Island doctor says it could also save lives. The IvyGene test requires a few vials of blood to tell you if you may already be developing cancer cells in your body.

Read More

New York Onco-Immunologist Pioneers the Use of Advanced Cancer Test: IvyGene

October 12, 2018Markets Insider

WESTBURY, N.Y., Oct. 12, 2018 /PRNewswire/ — Integrative Medicine of NY is one of the first clinical cancer facilities in the lower NY area to endorse and use the early detection and prevention lab test called IVYGENE. IMNY medical director Dr. Jesse Stoff is one of the first to support…

Read More

Introducing IvyGene: “Patient-Friendly” Advancement in Early Cancer Detection

September 19, 2018

“…the term ‘cancer’ is not a singular enemy; its a single term to represent hundreds of different cancer types– all unique to their location in the body and their origin, and that makes screening/treating them a very specialized and a highly customized procedure.”  Howard Prince, research specialist & patient advocate…

Read More

The New IvyGene Test for Breast Cancer – Breast Cancer Conqueror

May 21, 2018

By now you may know that there are MANY options for detecting Breast Cancer outside of traditional mammography, which may come with some dangerous side effects. One option that I have written about in the past is the Oncoblot test, created by Dr. Dorothy Morré and the late Dr. James…

Read More

Market Intel: Liquid Biopsies For Cancer Screening – Far From Reach Or Close At Hand?

May 11, 2018

While liquid biopsy is becoming routine for cancer treatment stratification and monitoring, using blood tests to screen for early cancer in asymptomatic people remains a tantalizing target. Some question how practical such a test could be but several companies are already en route – some further down the road than…

Read More

Mission to offer cancer screenings for firefighters

April 13, 2018

Mission will soon begin testing their firefighters for cancer. The Mission City Council authorized the purchase of IvyGene tests, a blood test that can detect the presence of certain diseases, including colon, liver and lung cancer. “We’re doing this for the firefighters obviously because of their working environment and what…

Read More

Liquid biopsy may be new way to detect liver cancer earlier, easier

October 9, 2017

An international team of researchers at University of California San Diego School of Medicine and Moores Cancer Center, with colleagues at Sun Yet-sun University Cancer Center and other collaborating institutions, have developed a new diagnostic and prognosis method for early detection of hepatocellular carcinoma (HCC), based on a simple blood sample containing circulating tumor DNA.

Read More